Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × Sensitivity and Specificity × Clear all

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT02944162 2016-12-06

CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML

Phase 1/2 Unknown

10 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML